Record Details

Aluminium in Alzheimer's disease: are we still at a crossroad?

IR@CSIR-CFTRI

View Archive Info
 
 
Field Value
 
Relation http://ir.cftri.com/2007/
10.1007/s00018-004-4317-3
 
Title Aluminium in Alzheimer's disease: are we still at a crossroad?
 
Creator Gupta, Veer Bala
Anitha, S.
Hegde, M. L.
Zecca, L.
Garruto, R. M.
Ravi, R.
Shankar, S. K.
Stein, R.
Shanmugavelu, P.
Jagannatha Rao, K. S.
 
Subject 11 Food Biochemistry
 
Description Aluminium, an environmentally abundant non-redox trivalent cation has long been implicated in the pathogenesis of Alzheimer's disease (AD). However, the definite mechanism of aluminium toxicity in AD is not known. Evidence suggests that trace metal homeostasis plays a crucial role in the normal functioning of the brain, and any disturbance in it can exacerbate events associated with AD. The present paper reviews the scientific literature linking aluminium with AD. The focus is on aluminium levels in brain, region-specific and subcellular distribution, its relation to neurofibrillary tangles, amyloid beta, and other metals. A detailed mechanism of the role of aluminium in oxidative stress and cell death is highlighted. The importance of complex speciation chemistry of aluminium in relation to biology has been emphasized. The debatable role of aluminium in AD and the cross-talk between aluminium and genetic susceptibility are also discussed. Finally, it is concluded based on extensive literature that the neurotoxic effects of aluminium are beyond any doubt, and aluminium as a factor in AD cannot be discarded. However, whether aluminium is a sole factor in AD and whether it is a factor in all AD cases still needs to be understood.
 
Date 2005
 
Type Article
PeerReviewed
 
Format application/pdf
 
Language en
 
Rights
 
Identifier http://ir.cftri.com/2007/1/cellmlsci62%282%29143-158.pdf
Gupta, Veer Bala and Anitha, S. and Hegde, M. L. and Zecca, L. and Garruto, R. M. and Ravi, R. and Shankar, S. K. and Stein, R. and Shanmugavelu, P. and Jagannatha Rao, K. S. (2005) Aluminium in Alzheimer's disease: are we still at a crossroad? CMLS, Cellular and Molecular Life Sciences, 62 (2). pp. 143-158. ISSN 1420-682X